quantumbiopharma.com - QNTM Company profit before taxes, interest and amortization
Quantum BioPharma Ltd (QNTM) operations within a strictly regulated environment are complicated by frequent strategy shifts, which weaken the business's economic moat. The company's EBITDA visualizes this process, with the indicator currently standing at 0.00. The firm is developing potential in the field of cannabinoid-based pain therapy. Growth prospects are based on the success of a diversified portfolio and the influx of new investments.
Summary analytical data breakdowns for Quantum BioPharma (QNTM)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Quantum BioPharma Ltd|QNTM - Long-Term Debt to Equity|Short-Term Indebtedness to Equity Quantum BioPharma Ltd.|QNTM - Company Total Debt|Debts to Book Capitalization Quantum BioPharma|QNTM - Company Long-Term Debts|Company Short-Term Debts Quantum BioPharma|Immediate Liquidity Ratio quantumbiopharma.com
- earnings and market ratios statistics:
QNTM - Net Income|Future Net Profit Quantum BioPharma Ltd|QNTM - Price to Earnings Ratio|Forward P/E Multiple quantumbiopharma.com|QNTM - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Quantum BioPharma|QNTM - Operating profit before deduction of amortization|Earnings per share for the trailing year Quantum BioPharma|QNTM - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months quantumbiopharma.com|QNTM - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Quantum BioPharma Ltd
Fundamental company valuation:QNTM (Quantum BioPharma Corp)
For Quantum BioPharma Ltd (QNTM), this indicator reflects actual cash inflows from patent licensing fees for inflammation therapies, excluding any accounting assumptions. Analyzing operating profit trends reveals the cyclicality of royalty income and assesses the sustainability of the business model, where local dips on the chart serve as signals for identifying entry points or evaluating the risks of a deep correction.
Who Quantum BioPharma Ltd competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|Operating profit before depreciation charges ANI Pharmaceuticals Inc|MNKD: Operating profit before deduction of amortization|AMPH - Operating profit EBITDA|PCRX: Operating profit EBITDA|ars-pharma.com (SPRY) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Theravance Biopharma, Inc.|Operating profit before amortization AQST (Aquestive Therapeutics Inc)|Operating profit before deduction of amortization SCPH (scPharmaceuticals Inc.)|Company profit before taxes, interest and amortization TECX|Tonix Pharmaceuticals - Operating profit before deduction of amortization|Operating profit EBITDA SXT Pharmaceuticals SXTC|EPRX - Profit before payment of interest, taxes and amortization|BioHarvest Sciences, Inc. (BHST) - Operating profit before deduction of amortization|EXOZ (Invizyne Technologies, Inc.) - Operating profit before deduction of amortization|Oramed Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|ENTX (Entera Bio Ltd) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization HYFT|Operating profit EBITDA ABVC|Operating income before deduction of amortization Cumberland Pharmaceuticals Inc|Profit before payment of interest, taxes and amortization FibroGen Corp FGEN|Telomir Pharmaceuticals Corp (TELO) - Profit before interest, taxes and amortization|RANI - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization SNYR|RLYB: Operating profit EBITDA|Lexaria Bioscience Corp. - Income before deduction of interest, taxes and amortization|PULM (Pulmatrix Corp) - Operating profit EBITDA|Operating profit EBITDA Pheton|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|LYRA (lyratherapeutics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|TNFA - Operating profit before deduction of amortization|cbdMD Corp - Operating profit EBITDA|PRFX - Operating profit EBITDA|CYTO (altamiratherapeutics.com) - Operating profit before deduction of amortization|lipella.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization OptiNose|Profit before payment of interest, taxes and amortization PIRS|Operating profit before deduction of amortization PROC (Procaps Group SA)|Company profit before taxes, interest and amortization PTPI|Operating profit EBITDA QLI (Qilian International)|SLRN: Operating profit before amortization|TFFP - Profit before payment of interest, taxes and amortization
